NEW YORK (GenomeWeb News) – Illumina today said that it has filed a second patent infringement suit against Complete Genomics, following an earlier patent suit in 2010.

In the new suit, filed in the US District Court for the Southern District of California, Illumina claims that Complete Genomics' combinatorial probe-anchor ligation read technology infringes its US Patent No. 8,192,930, entitled "Method for sequencing a polynucleotide template."

Illumina said it is seeking "all available remedies, including injunctive relief."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.